Blue Cross NC policies, page 2

Search Blue Cross NC's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

1,022 public policies Substrate tracks for Blue Cross NC, by title.

Blue Cross NC policies
PolicyDetailsCodesSource
Baroreflex Stimulation DevicesCommercial16Original policy ↗
BCR-ABL1 Testing for Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia AHS - M2027M2027 · Commercial6Original policy ↗
Behavioral Health Discharge NoteBNCCARE-0087-20 · Medicaid—Original policy ↗
Behavioral Health Initial ReviewBNCCARE-0088-20 · Medicaid—Original policy ↗
Benefits of Utilization Management Attestations: A Guide from Providers (PDF)NCBCBS-CR-083955-25-CPN83578 · Medicaid—Original policy ↗
Beta-Hemolytic Streptococcus Testing AHS – G2159G2159 · Commercial24Original policy ↗
Biochemical Markers of Alzheimer Disease and Dementia AHS – G2048G2048 · Commercial25Original policy ↗
Biochemical Markers of Alzheimers Disease AHS – G2048G2048 · Commercial3Original policy ↗
Bioengineered Skin and Soft Tissue Substitute for Breast Reconstruction, Epidermolysis Bullosa Dystrophica (EBD), and Severe BurnsEffective Aug 21, 20257Original policy ↗
Bioengineered Skin and Soft Tissue Substitute for Diabetic Neuropathic Foot Ulcers, Vascular Insufficiency Ulcer and Chronic Pressure Non-Healing Wounds241Original policy ↗
Bioengineered Skin and Soft Tissue Substitute for Diabetic Neuropathic Foot Ulcers, Vascular Insufficiency Ulcer and Chronic Pressure Non-Healing Wounds NotificationMedicaid239Original policy ↗
Bioengineered Skin and Tissue "Notification"Commercial170Original policy ↗
Bioimpedance Devices for Detection of LymphedemaCommercial2Original policy ↗
Biomarker Testing for Autoimmune Rheumatic Disease AHS - G2022G2022 · Commercial17Original policy ↗
Biomarker Testing for Autoimmune Rheumatic Disease AHS - G2022 NotificationG2022 · Commercial16Original policy ↗
Biomarker Testing for Autoimmune Rheumatic Disease AHS – G2022G2022 · Commercial9Original policy ↗
Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases AHS – G2123G2123 · Commercial14Original policy ↗
Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases AHS – G2123G2123 · Commercial6Original policy ↗
Biomarkers for Myocardial Infarction and Chronic Heart Failure AHS - G2150G2150 · Commercial17Original policy ↗
Biomarkers for Myocardial Infarction and Chronic Heart Failure AHS – G2150G2150 · Commercial15Original policy ↗
BioZorb®Commercial4Original policy ↗
BioZorb®Commercial4Original policy ↗
Blue Cross and Blue Shield of North Carolina Expands Specialty Pharmacy Recertification List (August 2024 Pt. 2) (PDF)NCBCBS-CR-064675-24-CPN64481 · Medicaid3Original policy ↗
BLUE CROSS BLUE SHIELD FEP DENTAL® 2025 DENTAL OFFICE PROVIDER USER GUIDECommercial5Original policy ↗
Blue Cross NC Expands Specialty Pharmacy Precertification Lists (PDF)NCBCBS-CR-088119-25-CPN87562 · Medicaid2Original policy ↗
Blue High Performance Network Supplement (PDF)Commercial—Original policy ↗
Bone Mineral Density StudiesCommercial33Original policy ↗
Bone Morphogenetic ProteinCommercial4Original policy ↗
Bone Turnover Markers Testing AHS - G2051G2051 · Commercial8Original policy ↗
Brachytherapy, Intracavitary Balloon Catheter for Brain CancerCommercial8Original policy ↗
BRAF Genetic Testing In Patients With Melanoma AHS-M2029AHS-M2029 · Commercial12Original policy ↗
Breast SurgeriesCommercial41Original policy ↗
Bridging The Gap: Enhancing Medication Adherence For Better Health OutcomesNCBCBS-CR-082145-25-CPN81467 · Medicaid—Original policy ↗
Bronchial ThermoplastyCommercial10Original policy ↗
Bundling GuidelinesCommercial302Original policy ↗
Bundling GuidelinesCommercial297Original policy ↗
Bundling GuidelinesCommercial296Original policy ↗
Bundling GuidelinesCommercial298Original policy ↗
Bundling GuidelinesCommercial297Original policy ↗
Bundling GuidelinesCommercial302Original policy ↗
Bundling GuidelinesCommercial302Original policy ↗
Bundling GuidelinesCommercial302Original policy ↗
Bundling GuidelinesCommercial302Original policy ↗
Bundling Guidelines19Original policy ↗
Bundling Guidelines21Original policy ↗
Bundling Guidelines21Original policy ↗
Cancer Status – 30-Second Bedside Check (PDF)Commercial—Original policy ↗
Capsule Endoscopy, WirelessCommercial9Original policy ↗
Cardiac (Heart) TransplantationCommercial4Original policy ↗
Cardiac Monitoring Devices in the Outpatient SettingCommercial23Original policy ↗

Back to Blue Cross NC · Blue Cross NC prior authorization CPT list

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.